Revascularization strategies for patients with established chronic coronary syndrome.
Casper F CoerkampMarieke HoogewerfBart P van PutteYolande AppelmanPieter A DoevendansPublished in: European journal of clinical investigation (2022)
Coronary artery disease is the most common type of cardiovascular disease, leading to high mortality rates worldwide. Although the vast majority can be treated effectively and safely by medical therapy, revascularization strategies remain essential for numerous patients. Outcomes of both percutaneous coronary intervention and coronary artery bypass grafting improve in a rapid pace, resulting from technical innovation and ongoing research. Progress has been achieved by technical improvements in coronary stents, optimal coronary target and graft selection, and the availability of minimally invasive surgical strategies. Besides technical progress, evidence-based patient-tailored decision-making by the Heart Team is the basic precondition for optimal outcome. The combination of fast innovation and long-term clinical evaluations creates a dynamic field. Research outcomes should be carefully interpreted according to the techniques used and the trial's design. Therefore, more and more trial outcomes suggest that revascularization strategies should be tailored towards the specific patient. Although the European Society of Cardiology/European Association for Cardio-Thoracic Surgery guidelines on myocardial revascularization date from 2018 and a large variety of trial outcomes on revascularization strategies in chronic coronary syndrome have been published since, we aim to provide an updated overview within this review.
Keyphrases
- coronary artery disease
- coronary artery bypass grafting
- percutaneous coronary intervention
- cardiovascular events
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- antiplatelet therapy
- cardiovascular disease
- acute coronary syndrome
- coronary artery
- study protocol
- minimally invasive
- clinical trial
- decision making
- phase iii
- heart failure
- newly diagnosed
- aortic stenosis
- thoracic surgery
- ejection fraction
- risk factors
- coronary artery bypass
- healthcare
- palliative care
- mesenchymal stem cells
- end stage renal disease
- type diabetes
- randomized controlled trial
- adipose tissue
- insulin resistance
- prognostic factors
- left ventricular
- open label
- systematic review
- skeletal muscle
- peritoneal dialysis
- quality improvement